Please login to the form below

Issues facing brand teams and how agencies help to deliver value

We interviewed Wayne Atherden, Procurement Director Commercial Services at Janssen, to get his view on the issues facing brand teams and how agencies help to deliver value.
At Blue Latitude Health, we place a lot of importance on establishing and maintaining long-term, value-adding relationships with our clients. As a result of our continued focus on building trust and delivering results for Janssen, back in September 2015 we were re-appointed for another three years to provide strategic support and creative marketing services for their brand teams in the EMEA region.

We interviewed Wayne Atherden, Procurement Director Commercial Services at Janssen, our European procurement contact, to get a fuller understanding of his view on the issues facing brand teams and how agencies help to deliver value. Here is what he had to say.

Q: Digital and multichannel marketing has clearly changed the way that marketing brand teams work. Can you tell us a bit more about how this has affected brand teams at Janssen? 

Wayne: "The shift has highlighted even more acutely the need to better understand our customers – where do they go for information, how do they prefer to interact with pharma companies, how do they get answers to their questions? We need to customise the channels we use to the type of healthcare professional (HCP), so as to optimise our investments and maximise impact.

As options have multiplied, we need to be more discerning, to focus on areas that really make a difference. Our agencies have a key role in helping us achieve this, by using market and customer insights to help shape our strategies."



Read the full interview in our special supplement to Perspective magazine

2nd March 2016

Share

Tags

Company Details

Blue Latitude Health

+44 203 328 1840

Contact Website

Address:
Blue Latitude Health (UK)
140 Aldersgate Street
London
EC1A 4HY
United Kingdom

Latest content on this profile

Precision medicine at Blue Latitude Health
At Blue Latitude Health we have identified 90+ insights about commercialising precision medicines. Check out our video to get a run down on three core components of the commercialisation and launch of precision medicines.
Blue Latitude Health
Understanding the evolving CAR-T market
In 2017 the approval of the first CAR-T treatment took the world by storm, transforming the way cancer is treated, but two years later more than 500 CAR-Ts are in development. So how can pharma ensure its product stands out from the crowd?
Blue Latitude Health
How ready are you for launch?
Pharmaceutical launches are becoming more complex and competitive. Our launch excellence diagnostic tool helps you to map how ready you are for launch, while facilitating success in this challenging environment.
Blue Latitude Health
Does your pre-launch strategy really drive behaviour change?
One of the most interesting parts of a pharmaceutical launch is delving into the minds of stakeholders to understand why they behave in the way that they do. Blue Latitude Health Insight Consultant, Dorrotya Okros, examines how we use these insights to understand customers decision making behaviour, in order to make smarter business decisions.
Blue Latitude Health
Digitalising healthcare: what can the NHS learn from other industries?
Expensive digital solutions are often disregarded because they do not work well for the end user. Account Manager Fiona Grace explores this challenge and reveals the stories of innovation we can all learn from.
Blue Latitude Health
UK vs US: what makes a successful immunisation programme?
Emily Macdonald calls on her experience as a public health nurse specialising in the prevention of infectious disease in both the US and UK, to explore the differences between immunisation programmes in the two countries. She explores the challenges, opportunities for improvement, and asks why vaccination rates are falling.
Blue Latitude Health